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egja.2012Abstract Objective: Sedation is an effective component of care in ICU patients. The aim of this
study was to evaluate the safety and efﬁcacy of ketamine/propofol combination in short term seda-
tion for the critically ill patients in ICU.
Design: Prospective case series study.
Setting: Intensive care unit (ICU) in a tertiary hospital (Kasr Al Aini).
Methods: Fourteen critically ill patients who were mechanically ventilated and were in need for
sedation were included in this case series. An initial bolus dose (500 lg/kg) of ketamine/propofol
1:1 (ketamine 8 mg/ml and propofol 8 mg/ml) was given to all patients followed by a maintenance
dose of 10 lg/kg/min and the infusion dose adjusted (in 5 lg/kg/min increments) to achieve Ramsay
Sedation Scale of 4. Recorded parameters included heart rate, systolic blood pressure, Ramsay
score, the need for use of noradrenalin and the recovery time from discontinuation of sedation.
Results: The mean and standard deviation of the age of the patients was 60 ± 14.5 y and their
APACHEII score ranged from 18 to 35. The median initial bolus dose of ketofol administered
was 5 ml of aliquot with median infusion rate 6 ml/h (range: 4.8–7.5 ml/h) only three patients
(21.4%) needed the infusion rate to be increased to achieve Ramsay score 4. Only one patient expe-
rienced hypotension due to hypovolemia secondary to internal hemorrhage.
Conclusion: Continuous intravenous infusion of ketofol may provide adequate and safe short term
sedation (less than 24 h) for critically ill patients in the intensive care units, with rapid recovery and
no clinically signiﬁcant complications. Further studies with larger number of patients are required
to evaluate and validate these ﬁndings.
ª 2012 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.ail.com (A. Zaghloul).
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Critically ill patients in an intensive care unit (ICU) are sub-
jected to a variety of noxious stimuli including pain after sur-
gery, frequent venipuncture, invasive monitoring and
endotracheal intubation [1]. So Sedation is considered as an
essential component of care in these patients.hosting by Elsevier B.V. Open access under CC BY-NC-ND license.
Table 1 Ramsay Sedation Scale [20].
Sedation
level
Description
1 Patient is anxious and agitated or restless, or both
2 Patient is co-operative, oriented, and tranquil
3 Patient responds to commands only
4 Patient exhibits brisk response to light glabellar tap or
loud auditory stimulus
5 Patient exhibits a sluggish response to light glabellar
tap or loud auditory stimulus
6 Patient exhibits no response
180 W. Hamimy et al.The aim of using sedation is to reduce stress, and to pro-
vide anxiolysis, analgesia and amnesia without compromizing
the cardiovascular and respiratory system. Systolic blood
pressure (SBP) and heart rate (HR) were recorded before
starting sedation (T0), then after 15 min (T1), 30 min (T2),
1 h (T3), 3 h (T4), 6 h (T5) and 12 h (T6) after starting
sedation.
The ideal sedative should be effective, short-acting and
non-cumulative, free of adverse effects, having rapid onset
and offset, with no effect on the metabolism of other drugs
and lastly should have known pharmacokinetics and pharma-
codynamics in organ failure. The drugs commonly used for
sedation in the ICU include benzodiazepines, antipsychotics
and propofol, none of which meets all these criteria.
Multiple studies evaluated the safety of intravenous keta-
mine/propofol combination (‘‘ketofol’’) in the same syringe
[2–4].
Propofol is a short-acting intravenously administered sed-
ative and hypnotic agent that can be used for the induction
and maintenance of general anesthesia, sedation for intu-
bated, mechanically ventilated patients in the ICU, and in
procedures such as colonoscopy. It does not have analgesic
properties [5]. The adverse effects related to the use of propo-
fol include dose-dependent hypotension and respiratory
depression [6–8].
Ketamine is classiﬁed as an NMDA receptor antagonist
and has also been found to bind to opioid receptors and sigma
receptors. It induces a state referred to as ‘‘dissociative anes-
thesia’’ [9]. It provides amnesia, analgesia and anesthesia while
maintaining protective airway reﬂexes and spontaneous respi-
ration [10,11]. Its signiﬁcant adverse effects include its propen-
sity to cause vivid and frightening emergent reactions [12],
sympathomimetic effects and vomiting when administered in
sedating doses [13].
Ketamine and propofol are physically compatible for 1 h at
23 C with no increase in particle content at Y site injection
[14]. Ketofol (ketamine/propofol combination) was used for
procedural sedation and analgesia (PSA). Ketamine and pro-
pofol administered in combination have offered effective seda-
tion for spinal anesthesia and for gynecologic, ophthalmologic,
and cardiovascular procedures in all age groups [15]. Also it
has been used as an infusion for sedation in awake craniotomy
cases safely with minimal hemodynamic and respiratory events
and with rapid smooth recovery proﬁle [16]. The opposing
hemodynamic and respiratory effects of each drug may en-
hance the utility of this drug combination, increasing both
safety and efﬁcacy while minimizing their respective adverse ef-
fects. This is due partly to the fact that many of the potential
side effects are dose-dependent, and when administrating this
combination the doses of each drug can be reduced [17]. There
is a signiﬁcant amount of literature describing the use of keto-
fol in infusion form.
Because ketofol is considered a relatively new idea for
most practitioners, there is very little or nearly no data avail-
able in scientiﬁc literature for its use as a sedative in ICUs.
Propofol is recommended as one of the preferred agents for
the short-term (<24 h) treatment of anxiety in the critically
ill adults [18] and continuous infusion doses of ketamine have
been also described for 24 h [19], so ketofol is expected to be
given safely as a continuous infusion for 24 h (short-term
sedation).The aim of this study was to evaluate safety and efﬁcacy of
using ketofol for short term sedation for critically ill patients in
the intensive care unit.2. Patients and methods
After approval of this case series prospective study by the local
Ethics Committee, critically ill patients (who were deﬁned as
those patients requiring intensive monitoring and may poten-
tially need immediate intervention) who were mechanically
ventilated and in need for sedation were included excluding pa-
tients less than 18 years old, head trauma patients or those
with increased intracranial tension, epileptic patients and pa-
tients with known allergies to the studied drugs.
Ketofol (propofol/ketamine admixture) was prepared by an
assistant who was not involved in the clinical management of
the study patients. a ketofol (1:1): propofol 8 mg/ml, ketamine
8 mg/ml by mixing 40 ml propofol 1% (10 mg/ml) with 8 ml
ketamine (50 mg/ml) and 2 ml dextrose 5% (each ml of aliquot
contained 8 mg propofol and 8 mg ketamine).
Both bolus and maintenance doses will be given using syr-
inge pump (B/Braun). Set up for delivery of ketofol as an ini-
tial bolus of 500 lg/kg IV of aliquot, followed by an initial
maintenance infusion at 10 lg/kg/min and the infusion dose
adjusted (in 5 lg/kg/min increments) to achieve Ramsay Seda-
tion Scale of 4, maximum infusion time was 24 h.
The Ramsay score (target and actual) was recorded hourly
for the ﬁrst 24 h, and patients were continuously monitored for
ECG, blood pressure, oxygen saturation, doses of vasocon-
strictor agents (noradrenaline) were recorded before and dur-
ing infusion, development of side effects, recovery time and
APACHEII score will be recorded.
Systolic blood pressure (SBP) and heart rate (HR) were re-
corded before starting sedation (T0), then after 15 min (T1),
30 min (T2), 1 h (T3), 3 h (T4), 6 h (T5) and 12 h (T6) after start-
ing sedation.
Complications including hypotension which is deﬁned as
systolic blood pressure less than 90 (Table 1), hypertension
which is deﬁned as systolic blood pressure more than 170, respi-
ratory depression which is deﬁned as apnea more than 20 s were
recorded. Any change in the rate of infusion of vasoconstrictor
agent (noradrenaline) if present was recorded.
Recovery time was deﬁned as the time required for the pa-
tient to regain the baseline conscious level (conscious level be-
fore starting sedation) after discontinuing sedation.
Table 2 Hemodynamic changes, data are presented as mean ± sd.
T0 T1 T2 T3 T4 T5 T6
SBP 122.4 ± 16.2 119.2 ± 14.7 119.8 ± 15.4 128.9 ± 14.1 129.6 ± 11.9 138.2 ± 14.7 139.3 ± 14.5
HR 104.7 ± 19.3 101 ± 21.9 103 ± 19.2 97.5 ± 19.8 98.1 ± 22.8 95.5 ± 18.3 95.2 ± 18.5
SBP: Systolic blood pressure, HR: Heart rate; T0: time before starting sedation, T1: time after 15 min, T2: time after 30 min, T3: time after 1 h,
T4: time after 3 h, T5: time after 6 h, T6: time after 12 h of starting sedation.
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Continuous data were presented as mean ± standard devia-
tion or median, categorical data were presented as number
and percent. ANOVA was used to compare the recorded
hemodynamic parameters where P values less than 0.05 was
considered signiﬁcant. SPSS 17.0 (Statistical Package for the
Social Sciences) was used for statistical calculations.
4. Results
A total of 14 patients were enrolled for the study. Median
patient age was 63 years (range 32–84 y), 57.1% were males
and 42.9% were females, 10 patients (71.4%) were surgical
and four patients (28.6%) were medical, APACHEII score
(range18–35) all patients were mechanically ventilated and only
three patients (21.4%) were receiving noradrenaline infusion.
The median initial bolus dose of ketofol administered was
5 ml of aliquot with median infusion rate 6 ml/h (range: 4.8–
7.5 ml/h). The median infusion period was 16 h (range: 1–24 h).
There were no signiﬁcant changes observed in pulse rate
and blood pressure except one patient (7.1%) who became
hypotensive due to hypotension secondary to internal hemor-
rhage (Table 2).
Median recovery time was 30 min (range 18–60 min).
Non-signiﬁcant complications in the form of respiratory
depression and agitation were detected.
5. Discussion
The main ﬁnding of the current study was that, infusion of a
combination of ketamine–propofol in the same syringe was
effective in maintaining Ramsay Sedation Scale 4 without
hemodynamic instability.
Non-signiﬁcant changes in the form of hypertension, hypo-
tension were detected except one patient who experienced
hypotension due to hemorrhagic shock that followed postoper-
ative repair of hepatic injury for whom ketofol infusion was
stopped after 1 h of continuous infusion. Three patients were
receiving noradrenaline infusion before starting ketofol seda-
tion for whom we did not need to increase infusion rate of nor-
adrenaline after starting ketofol infusion.
In line with our results, several authors demonstrated the
safety of using ketofol on hemodynamics. Willman and
Andolfatto [21], reported that no patient became hypotensive
or had evidence of poor perfusion when ketofol was adminis-
trated in a mean dose of (0.75 mg/kg of ketamine and 0.75 mg/
kg of propofol) for PSA for mainly orthopedic procedures
conducted in the emergency department (ED) setting where
114 patients were enrolled in this study. Andolfatto and Will-
man [22], demonstrated that only 1 patient out of 728 patientsbecame hypotensive when ketofol was used for PSA for primar-
ily orthopedic procedures. Also Loh and Dalen [23], studied the
effect of ketofol in procedural sedation, they reported that few-
er patients given the ketamine–propofol combination experi-
enced signiﬁcant hemodynamic compromise, need for active
interventions, including ﬂuid or vasopressor administration.
They attributed their results to the contradictory effect of both
ketamine and propofol on autonomic nervous system, keta-
mine being sympathomimetic while propofol lessens this effect.
No respiratory depression or agitation were reported in the
cohort group. Similar to our ﬁndings Willman and Andolfatto
[21] reported that 3 out of 114 had transient hypoxia who re-
quired bag-valve-mask ventilation, four patients required
repositioning for airway malalignment, and three patients
(2.6%; 95% CI 0.6–7.5%) had mild unpleasant emergence,
of whom one received midazolam. Also Andolfatto and
Willman [22] who tried to evaluate the effectiveness, recovery
time, and adverse event proﬁle of intravenous (IV) mixed 1:1
ketamine–propofol for adult procedural sedation and analge-
sia in the emergency department where ketofol PSA was used
in 728 patients for primarily orthopedic procedures reported
that bag-mask ventilation occurred in 15 patients (2.1%) and
Recovery agitation occurred in 26 patients (3.6%) of whom
13 (1.8%) required treatment.
Median recovery time was 30 min (range 18–60 min) which
is comparable with Andolfatto and Willman [22] who demon-
strated that the median recovery time was 14 min (range 3–
50 min). Erden et al. [24] who reported that the mean recovery
times were 12.1±1 min in the patient group underwent inter-
ventional radiological procedures under sedation who received
propofol 0.5 mg kg1 + ketamine 0.5 mg kg1. In our study
the median recovery time seems to be longer may be due to
the longer infusion period.
Limitations: The study group was small and so reporting of
adverse events is limited also ketofol was not compared in a
randomized, blinded fashion to other ICU sedation regimens.
In conclusion continuous intravenous infusion of ketofol
may provide adequate and safe short term sedation (less than
24 h) for critically ill patients in the intensive care units, rapid
recovery and no clinically signiﬁcant complications. Because of
the small size of this case series further studies with larger
number of patients are required to evaluate and validate these
ﬁndings.
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